Abelson P, Kennedy D. The obesity epidemic. Science 2004;304:1413.
PubMed
Article
CAS
Google Scholar
Hill JO, Melanson EL, Wyatt HT. Dietary fat intake and regulation of energy balance: Implications for obesity. J Nutr 2000; 130: 284S–288S.
PubMed
CAS
Google Scholar
Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Monson RR, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990;322:882–889.
PubMed
CAS
Google Scholar
Astrup A, Buemann B, Western P, Toubro S, Raben A, Christensen NJ. Obesity as an adaptation to a high-fat diet: evidence from a cross-sectional study. Am J Clin Nutri 1994;59:350–355.
CAS
Google Scholar
Campfield LA, Smith FJ, Burn P. Strategies and potential molecular targets for obesity treatment. Science 1998; 280:1383–1387.
PubMed
Article
CAS
Google Scholar
Bray GA, Greenway FL. Current and potential drugs for treatment of obesity. Endocr Rev 1999;20:805–875.
PubMed
Article
CAS
Google Scholar
Han LK, Takaku T, Li J, Kimura Y, Okuda H. Anti-obesity action of oolong tea. Int J Obes 1999;23:98–105.
Article
CAS
Google Scholar
Kuo KL, Weng MS, Chiang CT, Tsai YJ, Lin-Shiau SY, Lin JK. Comparative studies on the hypolipidemic and growth suppressive effects of oolong, black, pu-erh, and green tea leaves in rats. J Agric Food Chem 2005; 53:489–489.
Google Scholar
Rumpler W, Seale J, Clevidence B, Judd J, Wiley E, Yamamoto S, et al. Oolong tea increases metabolic rate and fat oxidation in men. J Nutr 2001;131:2848–2852.
PubMed
CAS
Google Scholar
Okuda H, Han LK. Medicinal plant and its related metabolic modulators. Nippon Yakurigaku Zasshi 2001;118:347–351.
PubMed
CAS
Google Scholar
Davies MJ, Judd JT, Baer DJ, Clevidence BA, Paul DR, Edwards AJ, et al. Black tea consumption reduces total and LDL cholesterol in mildly hypercholesterolemic adults. J Nutr 2003;133:3298–3302.
Google Scholar
Khosla T, Lowe CR. Indices of obesity derived from body weight and height. Br J Prev Soc Med 1967;21:122–128.
PubMed
CAS
Google Scholar
WHO Physical Status: The use and interpretation of anthropometry. Report of a WHO expert committee Geneva: World Health Organization Technical Report Seriels; 1995:854.
WHO. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on obesity, Geneva 3–5, June 1997. World Health Organization Techinical Report Series. Vol. 210. Geneva: World Health Organization;1997:1–276.
Google Scholar
Xie B, Shi H, Chen Q, Ho CT. Antioxidant properties of fractions and polyphenol constituents from green, oolong and black teas. Proc Natl Sci Counc Repub China (B) 1993;17:77–84.
CAS
Google Scholar
Bitou N, Ninomiya M, Tsujita T, Okuda H. Screening of lipase inhibitors from marine algae. Lipids 1999;34:441–445.
PubMed
Article
CAS
Google Scholar
Golor G, Yamashita K, Koner W, Hagenmaier H, Neubert D. Kinetics and inductive potency of 1, 2, 3, 4, 6, 7, 8-heptachlorodibenzo-p-dioxin (H7CDD) in rats. Life Sci 2001;69:493–508.
PubMed
Article
CAS
Google Scholar
Saris W. Sugars, energy metabolism, and body weight control. Am J Clini Nutri 2003;78:850–857.
Google Scholar
Iwata K, Inayama T, Miw S, Kawaguchi K, Koike G. Effect of oolong tea on plasma lipids and lipoprotein lipase activity in young women. J Jpn Soc Nutr Food Sci 1991;44:251–259.
CAS
Google Scholar
Lin YS, Tsai YJ, Tsay JS, Lin JK. Factors affecting the levels of tea polyphenols and caffeine in tea leaves. J Agric Food Chem 2003;51:1864–1873.
PubMed
Article
CAS
Google Scholar
Dulloo AG, Dure C, Rohrer D, Girardier L, Mensi N, Fathi M. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutri 1999;70:1040–1045.
CAS
Google Scholar
Bianchi CP. Cellular pharmacology of contraction of skeletal muscle. In: Narahashi T, ed. Cellular pharmacology of excitable tissues. Charles C: Thomas Publisher;1975:485–519.
Google Scholar
Arciero PJ, Gardner AW, Calles-Escandon J, Benowitz NL, Poehlman ET. Effects of caffeine ingestion on NE kinetics, fat oxidation, and energy expenditure in younger and older men. Am J Physiol 1995;268:E1192–E1198.
PubMed
CAS
Google Scholar
Couturier C, Janvier B, Girlich D, Bereziat G, Andreani-Mangeney M. Effects of caffeine on lipoprotein lipase gene expression during the adipocyte differentiation process. Lipids 1998;33:455–460.
PubMed
Article
CAS
Google Scholar
Mulder H, Holst LS, Svensson H, Degerman E, Sundler F, Ahren B. Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells. Diabetes 1999;48: 228–232.
PubMed
Article
CAS
Google Scholar
Kao YH, Hiipakka RA, Liao S. Modulation of obesity by green tea catechins. Am J Clin Nutr 2000;72:1232–1233.
PubMed
CAS
Google Scholar
Watanabe J, Kawabata J, Niki R. Isolation and identification of acetyl-CoA carboxylase inhibitors from green tea (Camellia sinensis). Biosci Biotechnol Biochem 1998;62:532–534.
PubMed
Article
CAS
Google Scholar
Nakahara K, Izumi R, Kodama T, Kiso Y, Tanaka T. Inhibition of postprandial hyperglycaemia by oolong tea extract (OTE). Phytother Res 1994;8:433–435.
Article
Google Scholar
Han LK, Kimura Y, Kawashima M, Takaku T, Taniyama T, Hayashi T, et al. Anti-obesity effects in rodents of dietary teasaponin, a lipase inhibitor. Int J Obes 2001;25:1459–1464.
Article
CAS
Google Scholar
Inui Y, Kawata S, Matsuzawa Y, Tokunaga K, Fujioka A, Tamura S, et al. Increased level of apolipoprotein B mRNA in the liver of ventromedial hypothalamus lesioned obese rats. Biochim Biophys Res Commun 1989;163:1107–1112.
Article
CAS
Google Scholar
Wang SR, Infante J, Catala D, Petit D, Bonnefis MT, Infante R. Lipid and lipoprotein synthesis in isolated and cultured hepatocytes from lean and obese Zucker rats. Biochim Acta 1989;1002:302–311.
CAS
Google Scholar
Garrison RJ, Wilson PW, Castelli WP, Feinleib M, Kannel WB, McNamara PM. Obesity and lipoprotein cholesterol in the Framingham offspring study. Metabolism 1980;29:1053–1060.
PubMed
Article
CAS
Google Scholar
Chisaka T, Matsuda H, Kubomura Y, Mochizuki M, Yamahara J, Fujimura H. The effect of crude drugs on experimental hypercholesteremia: Mode of action of (-)-epigallocatechin gallate in tea leaves. Chem Pharm Bull 1988;36:227–233.
PubMed
CAS
Google Scholar
Ikeda I, Imasato Y, Sasaki E, Nakayama M, Nagao T, Takeo T, et al. Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochim Biophys Acta 1992;1127:141–146.
PubMed
CAS
Google Scholar
Okuda T, Kimura Y, Yoshida T, Hatano T, Okuda H, Arichi S. Studies on the activities of tannins and related compounds from medicinal plants and drugs. I. Inhibitory effects on lipid peroxdation in mitochondria and microsomes of liver. Chem Pharm Bull 1983;31:1625–1631.
PubMed
CAS
Google Scholar
Muramatsu K, Fukuyo M, Hara Y. Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J Nutr Sci Vitaminol 1986;32:613–622.
PubMed
CAS
Google Scholar
Matsuda H, Chisaka T, Kubomura Y, Yamahara J, Sawada T, Fujimura H. Effects of crude drugs on experimental hypercholesterolemia. I. Tea and its active principles. J Ethnopharmacol 1986;17:213–224.
PubMed
Article
CAS
Google Scholar
Hasegawa N, Yamda N, Mori M. Powdered green tea has antilipogenic effect on Zucker rats fed a high-fat diet. Phytother Res 2003;17:477–480.
PubMed
Article
Google Scholar
Matsuzawa Y. Life style-related disease. Nippon Rinsho 2001;59:188–194.
PubMed
CAS
Google Scholar